1. Home
  2. WAVE vs ELOX Comparison

WAVE vs ELOX Comparison

Compare WAVE & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eco Wave Power Global AB (publ)

WAVE

Eco Wave Power Global AB (publ)

HOLD

Current Price

$7.86

Market Cap

47.5M

Sector

Utilities

ML Signal

HOLD

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$11.64

Market Cap

41.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
WAVE
ELOX
Founded
2011
N/A
Country
Israel
United States
Employees
N/A
7
Industry
Electric Utilities: Central
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
47.5M
41.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
WAVE
ELOX
Price
$7.86
$11.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
60.6K
51.3K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$436.84
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.52
$10.00
52 Week High
$10.87
$15.00

Technical Indicators

Market Signals
Indicator
WAVE
ELOX
Relative Strength Index (RSI) 39.21 42.12
Support Level $6.73 $10.51
Resistance Level $8.49 $14.43
Average True Range (ATR) 0.48 1.76
MACD -0.15 0.07
Stochastic Oscillator 3.12 29.03

Price Performance

Historical Comparison
WAVE
ELOX

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient wave energy conversion, or WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographically, it has a presence in Israel, the USA, and Mexico.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: